Miles P Sparrow Selected Research

Immunologic Factors (Immunomodulators)

4/2021	Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's Disease.
10/2020	Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease.
11/2018	Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All.
1/2018	Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions.
10/2015	How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
12/2011	Response to Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2011 [Epub ahead of print].
9/2011	Thiopurine immunomodulators in ulcerative colitis: moving forward with current evidence.
8/2010	The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
9/2008	Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.
7/2008	Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miles P Sparrow Research Topics

Disease

33	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 12/2006
25	Crohn Disease (Crohn's Disease) 10/2022 - 12/2006
16	Ulcerative Colitis 06/2021 - 12/2006
7	Inflammation (Inflammations) 01/2022 - 12/2006
4	Pouchitis 10/2022 - 01/2019
4	Necrosis 05/2020 - 06/2015
3	Fistula 10/2022 - 04/2021
3	Colitis 02/2018 - 01/2017
2	Ileitis 10/2022 - 02/2018
2	Pathologic Constriction (Stenosis) 10/2022 - 04/2021
2	Lymphoma (Lymphomas) 10/2021 - 08/2010
2	Fatigue 10/2020 - 09/2009
2	Body Weight (Weight, Body) 01/2018 - 01/2014
2	Pancreatitis 05/2017 - 04/2011
2	Infections 01/2016 - 08/2010
1	Leukopenia 10/2021
1	Neoplasms (Cancer) 06/2021
1	Abscess 04/2021
1	Nausea 10/2020
1	Birth Weight (Birth Weights) 01/2020
1	Sclerosing Cholangitis 01/2019
1	Ulcer 02/2018
1	Hypersensitivity (Allergy) 05/2017
1	Hyperplasia 05/2017
1	Vitiligo 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 09/2011
1	Opportunistic Infections (Opportunistic Infection) 04/2011
1	Thrombocytopenia (Thrombopenia) 09/2009

Drug/Important Bio-Agent (IBA)

15	2-mercaptopurineIBA 10/2021 - 07/2008
12	Pharmaceutical PreparationsIBA 01/2022 - 09/2009
10	Infliximab (Remicade)FDA Link 01/2022 - 01/2016
10	Immunologic Factors (Immunomodulators)IBA 04/2021 - 07/2008
9	Azathioprine (Imuran)FDA LinkGeneric 05/2017 - 02/2007
9	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2017 - 02/2007
6	Adalimumab (Humira)FDA Link 01/2022 - 01/2016
6	Allopurinol (Remid)FDA LinkGeneric 05/2017 - 02/2007
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 06/2015
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2010
5	Biological ProductsIBA 04/2021 - 10/2008
5	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2014
3	Thioguanine (Tioguanine)FDA Link 11/2018 - 04/2011
3	C-Reactive ProteinIBA 02/2018 - 06/2015
3	Phenobarbital (Luminal)FDA Link 01/2014 - 12/2006
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2019
2	ontamalimabIBA 06/2021 - 01/2017
2	6-thioguanylic acidIBA 04/2021 - 11/2018
2	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2016
2	AntibodiesIBA 06/2017 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2011 - 07/2008
2	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2007 - 12/2006
2	AntigensIBA 04/2007 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 04/2007 - 12/2006
2	CytokinesIBA 04/2007 - 12/2006
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Nudix HydrolasesIBA 10/2021
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 10/2021
1	Monoclonal AntibodiesIBA 06/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	NucleotidesIBA 11/2018
1	IntegrinsIBA 11/2018
1	AlbuminsIBA 02/2018
1	vedolizumabIBA 01/2018
1	Bacterial AntibodiesIBA 06/2017
1	Prostaglandins AIBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	EnzymesIBA 09/2009

Therapy/Procedure

26	Therapeutics 01/2022 - 04/2008
7	Biological Therapy 10/2022 - 12/2009
2	Drug Therapy (Chemotherapy) 01/2018 - 06/2015
1	Ambulatory Care (Outpatient Care) 01/2020
1	Colectomy 02/2018
1	Restorative Proctocolectomy 02/2018
1	Salvage Therapy 01/2018
1	Remission Induction 01/2017
1	Intravenous Infusions 01/2014
1	Transplantation 01/2014